Morphosys Research Site

Seville 41014

0 studies enrolling now · 4 studies all time

What they study most

Diffuse Large B Cell Lymphoma, Diffuse Large B-cell Lymphoma, Non-Hodgkin Lymphoma

Studies at this site

• Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients — Running, not enrolling
• Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL — Completed
• Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL) — Completed
• Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL — Completed